LIBERVANT Trademark

Trademark Overview


On Friday, June 16, 2017, a trademark application was filed for LIBERVANT with the United States Patent and Trademark Office. The USPTO has given the LIBERVANT trademark a serial number of 87492329. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 4, 2021. This trademark is owned by MonoSol Rx, LLC. The LIBERVANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of neurological, cardiopulmonary, viral, metabolic, endocrine, musculoskeletal, genitourinary, gastrointestinal, oncological, autoimmune, inflammatory, pain, respiratory, hormonal, central nervous system, and psychiatric related diseases and disorders; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of epilepsy, anxiety disorders, seizure disorders, sleep disorders, insomnia, alcohol, opiate and benzodiazepine withdrawal syndrome, muscle spasms, and psychiatric disorders; pharmaceutical preparations, namely, anticonvulsants, antiseizure medications, psychotropics, benzodiazepines, sedatives, muscle relaxants, and mood stabilizing medications
libervant

General Information


Serial Number87492329
Word MarkLIBERVANT
Filing DateFriday, June 16, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 4, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 3, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of neurological, cardiopulmonary, viral, metabolic, endocrine, musculoskeletal, genitourinary, gastrointestinal, oncological, autoimmune, inflammatory, pain, respiratory, hormonal, central nervous system, and psychiatric related diseases and disorders; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of epilepsy, anxiety disorders, seizure disorders, sleep disorders, insomnia, alcohol, opiate and benzodiazepine withdrawal syndrome, muscle spasms, and psychiatric disorders; pharmaceutical preparations, namely, anticonvulsants, antiseizure medications, psychotropics, benzodiazepines, sedatives, muscle relaxants, and mood stabilizing medications

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 22, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAQUESTIVE THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressWARREN, NJ 07059

Party NameMonoSol Rx, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWarren, NJ 07059

Party NameMonoSol Rx, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWarren, NJ 07059

Trademark Events


Event DateEvent Description
Monday, January 4, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 4, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 27, 2020EXTENSION 5 GRANTED
Tuesday, May 12, 2020EXTENSION 5 FILED
Wednesday, May 27, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 12, 2020TEAS EXTENSION RECEIVED
Thursday, October 31, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 29, 2019EXTENSION 4 GRANTED
Tuesday, October 29, 2019EXTENSION 4 FILED
Tuesday, October 29, 2019TEAS EXTENSION RECEIVED
Tuesday, April 30, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 26, 2019EXTENSION 3 GRANTED
Friday, April 26, 2019EXTENSION 3 FILED
Friday, April 26, 2019TEAS EXTENSION RECEIVED
Saturday, October 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 25, 2018EXTENSION 2 GRANTED
Thursday, October 25, 2018EXTENSION 2 FILED
Thursday, October 25, 2018TEAS EXTENSION RECEIVED
Wednesday, May 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 30, 2018EXTENSION 1 GRANTED
Monday, April 30, 2018EXTENSION 1 FILED
Monday, April 30, 2018TEAS EXTENSION RECEIVED
Wednesday, January 31, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 3, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 13, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 24, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 22, 2017ASSIGNED TO EXAMINER
Thursday, June 22, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 20, 2017NEW APPLICATION ENTERED IN TRAM